M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT04132440
This trial studies patient and physician perspectives on non-alcoholic fatty liver disease. Using questionnaires and interviews, this trial may help researchers understand physicians' knowledge about the diagnosis, prognosis, treatment and management of non-alcoholic fatty liver disease, as well as gain an in-depth understanding of Hispanic patients' perceptions about the disease and investigate how cultural factors may play a role in its diagnosis, treatment and management.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Houston, Texas, 77030, United States
PRIMARY OBJECTIVES:
I. Explore the perceptions of non-alcoholic fatty liver disease (NAFLD), including knowledge, current practices for diagnosis and management, and additional disease-related perceptions amongst both primary care physicians.
II. Explore the perceptions of NAFLD, including knowledge, diagnosis and management, and additional disease-related perceptions amongst Hispanic patients.
OUTLINE:
Patients and physicians complete a questionnaire over 5 minutes and an interview over 30-45 minutes about thoughts on NAFLD, including what they know about NAFLD and its diagnosis, management, and monitoring, and other thoughts on NAFLD.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-None
Complete interview
Complete questionnaire
Time frame: Up to 1 year
Time frame: Up to 1 year
M.D. Anderson Cancer Center
Other
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease (NAFLD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05583344
Digestive System Diseases, Fatty Liver
Homewood, Alabama, United States
View Trial DetailsNCT05507151
Digestive System Diseases, Fatty Liver
Morgantown, West Virginia, United States
View Trial DetailsNCT05330923
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Beijing, Beijing Municipality, China
View Trial DetailsNCT06482112
Digestive System Diseases, Fatty Liver
Chandler, Arizona, United States
View Trial Details